dementia

Researchers caution that it’s too soon to recommend supplements based on the results of a new study.

Renewing the aging gut microbiome holds promise for preventing inflammatory brain and eye degeneration.

Observational evidence for the connection is solidifying, and some clues are emerging about the mechanisms that may explain it.

A new study reveals a network of neurons that, when disrupted, impairs adaptation to new circumstances in several types of dementia.

Author Lauren Aguirre finds reasons for optimism in the fight against Alzheimer’s disease.

Mice and flies given the polyamine in their diet have increased brain cell metabolism and cognitive function, and epidemiological data hints at a similar benefit in humans.

Patients who received the drug fared better cognitively and functionally than those taking placebo, but still experienced losses in performance.

The test will be a cheaper and more accessible alternative to currently available diagnostic tools, researchers say.

Accumulation of the protein was more likely to be found in the brains of people who slept less well years earlier, according to a new study.

Two copies of the APOE4 variant, which confers a higher risk of dementia, doubles the risk of severe symptoms as a result of infection with SARS-CoV-2, according to a study.

Digital biomarkers of cognitive decline could alert us to the early stages of dementia before irreversible damage occurs.

A woman whose DNA suggested she’d develop early-onset dementia staved off cognitive decline for decades.

Endolysosome leakiness allows tau to build up in cells.

Mutations within the MS4A gene cluster have been linked to changes in protein levels that affect disease risk.

The protein expression data, which are freely available online, could help identify new drug targets for the disease.

In a clinical trial, patients on the highest injected dose had 30 percent less cognitive decline over time than people on a placebo.

Alzheimer’s researcher John Hardy calls the departure “an unmitigated disaster” for science and healthcare in Britain.